Company intelligence / Profile preview

Nexus BioQuest

Bristol, England, United Kingdomnexusbioquest.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Nexus BioQuest is an active UK-based immunology-focused CRO founded in 2022. It provides bespoke preclinical research services to accelerate the development of immune therapeutics across oncology, autoimmunity, inflammation, and neuroinflammation. The company collaborates with pharmaceutical and biotechnology clients to design assays and generate data packages that inform early-stage drug development decisions. No clinical results are reported as it is not itself developing therapeutics.

Modalities: Cell therapyBiologicSmall molecule
Industry: Contract Research Organization

Partnerships

Not specified publicly; works with pharmaceutical and biotechnology companies on client projects.

Beyond the preview

Go deeper on Nexus BioQuest.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nexus BioQuest.

Explore the full profile